about
Neuroblastoma treatment in the post-genomic era.Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.MYCN induces neuroblastoma in primary neural crest cells.FGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation.Cell death-based treatment of neuroblastoma.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53 family: Therapeutic targets in neuroblastoma.
@en
p53 family: Therapeutic targets in neuroblastoma.
@nl
type
label
p53 family: Therapeutic targets in neuroblastoma.
@en
p53 family: Therapeutic targets in neuroblastoma.
@nl
prefLabel
p53 family: Therapeutic targets in neuroblastoma.
@en
p53 family: Therapeutic targets in neuroblastoma.
@nl
P2093
P2860
P356
P1433
P1476
p53 family: Therapeutic targets in neuroblastoma.
@en
P2093
Jennifer Wolter
Meredith Irwin
Paola Angelini
P2860
P304
P356
10.2217/FON.09.176
P407
P577
2010-03-01T00:00:00Z